https://www.indianpharmapost.com/biontech-bristol-myers-squibb-report-367-response-rate-for-experimental-lung-cancer-drug-222442026-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/lillys-experimental-lung-cancer-drug-shows-durable-responses-in-early-stage-trial-data-222452026-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazenecas-imfinzi-combination-cuts-risk-of-death-by-42-in-muscle-invasive-bladder-cancer-trial-222462026-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/roches-experimental-kidney-drug-cuts-proteinuria-by-431-in-phase-iii-trial-222472026-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/prostate-cancer-drug-cuts-risk-of-metastasis-or-death-by-58-in-high-risk-patients-phase-iii-trial-finds-222482026-10-27T00:00:00+05:30always0.9